Vik Chopra

Stock Analyst at BMO Capital

(1.49)
# 3,625
Out of 4,835 analysts
224
Total ratings
39.2%
Success rate
-0.1%
Average return

Stocks Rated by Vik Chopra

Envista Holdings
Sep 10, 2026
Reiterated: Hold
Price Target: $29
Current: $25.55
Upside: +13.50%
Stryker
Sep 9, 2026
Reiterated: Buy
Price Target: $369$317
Current: $275.56
Upside: +15.04%
Enovis
Sep 1, 2026
Rated: Buy
Price Target: $30$27
Current: $19.28
Upside: +40.04%
Intuitive Surgical
Aug 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $369.15
Upside: -
Globus Medical
Aug 27, 2026
Reiterated: Buy
Price Target: $94
Current: $74.19
Upside: +26.70%
Solventum
Aug 17, 2026
Reiterated: Hold
Price Target: $84
Current: $87.45
Upside: -3.95%
Align Technology
Aug 12, 2026
Reiterated: Buy
Price Target: $209
Current: $150.82
Upside: +38.58%
DENTSPLY SIRONA
Aug 6, 2026
Reiterated: Hold
Price Target: $12$13
Current: $10.46
Upside: +24.28%
Zimmer Biomet Holdings
Aug 6, 2026
Reiterated: Hold
Price Target: $95$96
Current: $93.49
Upside: +2.68%
Alphatec Holdings
Aug 5, 2026
Rated: Buy
Price Target: $11$12
Current: $10.58
Upside: +13.42%
Reiterated: Hold
Price Target: $85
Current: $88.36
Upside: -3.80%
Reiterated: Hold
Price Target: $70$71
Current: $63.93
Upside: +11.06%
Reiterated: Hold
Price Target: $19$18
Current: $15.60
Upside: +15.38%
Reiterated: Hold
Price Target: $36$45
Current: $46.30
Upside: -2.81%
Reiterated: Buy
Price Target: n/a
Current: $94.10
Upside: -
Initiated Coverage: Buy
Price Target: $159
Current: $130.96
Upside: +21.41%
Reiterated: Buy
Price Target: $15$19
Current: $14.04
Upside: +35.33%
Reiterated: Buy
Price Target: $109
Current: $84.37
Upside: n/a